INKILN is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10
Circulation · 04.07.2023 · 148 (1) · 47-67
DOI: 10.1161/circulationaha.123.063760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 04.07.2023. Verfasst von Wei Zhang und 26 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Center, Medical College of Georgia at Augusta University (W.Z., N.I., S.S., D.K., Q.L., G.W., H.W.K., W.B.B., N.L.W., J.M.M., X.L.). Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, RNA, Long Noncoding. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, British Heart Foundation.
Abstract (Originalsprache)
Background
Activation of vascular smooth muscle cell (VSMC) inflammation is vital to initiate vascular disease. The role of human-specific long noncoding RNAs in VSMC inflammation is poorly understood.
Methods
Bulk RNA sequencing in differentiated human VSMCs revealed a novel human-specific long noncoding RNA called inflammatory MKL1 (megakaryoblastic leukemia 1) interacting long noncoding RNA ( INKILN ). INKILN expression was assessed in multiple in vitro and ex vivo models of VSMC phenotypic modulation as well as human atherosclerosis and abdominal aortic aneurysm. The transcriptional regulation of INKILN was verified through luciferase reporter and chromatin immunoprecipitation assays. Loss-of-function and gain-of-function studies and multiple RNA–protein and protein–protein interaction assays were used to uncover a mechanistic role of INKILN in the VSMC proinflammatory gene program. Bacterial artificial chromosome transgenic mice were used to study INKILN expression and function in ligation injury–induced neointimal formation.
Results
INKILN expression is downregulated in contractile VSMCs and induced in human atherosclerosis and abdominal aortic aneurysm. INKILN is transcriptionally activated by the p65 pathway, partially through a predicted NF-κB (nuclear factor kappa B) site within its proximal promoter. INKILN activates proinflammatory gene expression in cultured human VSMCs and ex vivo cultured vessels. INKILN physically interacts with and stabilizes MKL1, a key activator of VSMC inflammation through the p65/NF-κB pathway. INKILN depletion blocks interleukin-1β–induced nuclear localization of both p65 and MKL1. Knockdown of INKILN abolishes the physical interaction between p65 and MKL1 and the luciferase activity of an NF-κB reporter. Furthermore, INKILN knockdown enhances MKL1 ubiquitination through reduced physical interaction with the deubiquitinating enzyme USP10 (ubiquitin-specific peptidase 10). INKILN is induced in injured carotid arteries and exacerbates ligation injury–induced neointimal formation in bacterial artificial chromosome transgenic mice.
Conclusions
These findings elucidate an important pathway of VSMC inflammation involving an INKILN /MKL1/USP10 regulatory axis. Human bacterial artificial chromosome transgenic mice offer a novel and physiologically relevant approach for investigating human-specific long noncoding RNAs under vascular disease conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vascular Biology Center, Medical College of Georgia at Augusta University (W.Z., N.I., S.S., D.K., Q.L., G.W., H.W.K., W.B.B., N.L.W., J.M.M., X.L.).
- Department of Molecular and Cellular Physiology, Albany Medical College, NY (J.Z., W.W., Y.W.L., P.G., M.C., M.M.B., X.L.).
- Centre for Cardiovascular Science, University of Edinburgh, Scotland (L.D., M.D.B., M.B., J.R., A.H.B.).
- Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University Munich, Germany (J.P., W.K., L.M.).
- Center for Public Health Genomics (A.W.T., C.L.M.), University of Virginia, Charlottesville.
- Department of Biochemistry and Molecular Genetics (C.L.M.), University of Virginia, Charlottesville.
ORCID-Profile: Wei Zhang, Nestor Ishimwe, Jessica Pauli, Shengshuai Shan, David Kim, Matthew Bennett, Julie Rodor, Yao Wei Lu, Mihyun Choi, Ha Won Kim, Margarida M Barroso, Clint L Miller, Neal L Weintraub, Lars Maegdefessel, Joseph M Miano, Andrew H Baker, Xiaochun Long
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- British Heart Foundation
- NIA NIH HHS
Zitieren
APA
Zhang, W., Zhao, J., Deng, L., Ishimwe, N., Pauli, J., Wu, W., Shan, S., Kempf, W., Ballantyne, M. D., Kim, D., Lyu, Q., Bennett, M., Rodor, J., Turner, A. W., Lu, Y. W., Gao, P., Choi, M., Warthi, G., Kim, H. W., …, & Long, X. (2023). INKILN is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10. Circulation, 148(1), 47-67. https://doi.org/10.1161/circulationaha.123.063760
Vancouver
Zhang W, Zhao J, Deng L, Ishimwe N, Pauli J, Wu W, et al. INKILN is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10. Circulation. 2023;148(1):47-67. doi:10.1161/circulationaha.123.063760
BibTeX
@article{Zhang2023,
author = {Zhang, Wei and Zhao, Jinjing and Deng, Lin and Ishimwe, Nestor and Pauli, Jessica and Wu, Wen and Shan, Shengshuai and Kempf, Wolfgang and Ballantyne, Margaret D and Kim, David and Lyu, Qing and Bennett, Matthew and Rodor, Julie and Turner, Adam W and Lu, Yao Wei and Gao, Ping and Choi, Mihyun and Warthi, Ganesh and Kim, Ha Won and Barroso, Margarida M and Bryant, William B and Miller, Clint L and Weintraub, Neal L and Maegdefessel, Lars and Miano, Joseph M and Baker, Andrew H and Long, Xiaochun},
title = {INKILN is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10},
journal = {Circulation},
year = {2023},
volume = {148},
number = {1},
pages = {47--67},
doi = {10.1161/circulationaha.123.063760}
}
EUVIMED